Scott Mendel's most recent trade in Quanterix Corp was a trade of 8,073 Restricted Stock Unit done . Disclosure was reported to the exchange on July 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quanterix Corp | Scott Mendel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2026 | 8,073 | 16,391 | - | - | Restricted Stock Unit | |
| Quanterix Corp | Scott Mendel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2026 | 8,073 | 24,056 (0%) | 0% | - | Common Stock | |
| Quanterix Corp | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 4.34 per share. | 01 Jul 2026 | 3,456 | 16,837 (0%) | 0% | 4.3 | 14,999 | Common Stock |
| QuantumSi Incorporated | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 251,185 | 251,185 | - | - | Stock Option (right to buy) | |
| Quanterix Corp | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 4,310 | 12,527 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 23,372 | 54,109 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 1,944 | 56,053 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 5.54 per share. | 01 Oct 2025 | 2,084 | 30,737 (0%) | 0% | 5.5 | 11,545 | Common Stock |
| Akoya Biosciences Inc | Scott Mendel | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 56,322 | 0 | - | - | Stock Option (right to buy) | |
| Quanterix Corp | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2025 | 50,758 | 50,758 | - | - | Stock Option (right to buy) | |
| Akoya Biosciences Inc | Scott Mendel | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 50,000 | 0 | - | - | Stock Option (right to buy) | |
| Akoya Biosciences Inc | Scott Mendel | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 44,959 | 0 | - | - | Stock Option (right to buy) | |
| Akoya Biosciences Inc | Scott Mendel | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 35,562 | 0 | - | - | Stock Option (right to buy) | |
| Akoya Biosciences Inc | Scott Mendel | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 30,549 | 0 | - | - | Stock Option (right to buy) | |
| Akoya Biosciences Inc | Scott Mendel | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 28,500 | 0 | - | - | Common Stock | |
| Quanterix Corp | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2025 | 24,464 | 28,653 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2025 | 4,189 | 4,189 (0%) | 0% | - | Common Stock | |
| QuantumSi Incorporated | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 126,095 | 126,095 | - | - | Stock Option (right to buy) | |
| Akoya Biosciences Inc | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 44,959 | 44,959 | - | - | Stock Option (right to buy) | |
| Akoya Biosciences Inc | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| QuantumSi Incorporated | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 113,281 | 113,281 | - | - | Stock Option (right to buy) | |
| Akoya Biosciences Inc | Scott Mendel | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 12 Jun 2023 | 20,000 | 28,500 | - | 5 | 100,000 | Common Stock |
| Akoya Biosciences Inc | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 56,322 | 56,322 | - | - | Stock Option (Right to Buy) | |
| QuantumSi Incorporated | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 141,843 | 141,843 | - | 0 | Class A Common Stock | |
| Akoya Biosciences Inc | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 30,549 | 30,549 | - | - | Stock Option (Right to Buy | |
| Akoya Biosciences Inc | Scott Mendel | Director | Purchase of securities on an exchange or from another person at price $ 13.16 per share. | 19 Nov 2021 | 8,500 | 8,500 | - | 13.2 | 111,860 | Common Stock |